We first found that a set of DEGs such as COL6A1, COL6A2, and COL6A3 are probably involved in the progression laryngeal cancer and MYCT1 inhibits the adhesion and migration of laryngeal cancer cells potentially through repression of COL6, suggesting that COL6 is a target downstream of MYCT1 and contributes to the progression of laryngeal cancer. The gene discussed is COL6A2; the disease is laryngeal carcinoma.